Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Qingre huazhuo tang regulates IgA nephropathy through immune checkpoints and ferroptosis.

  • 2025-10
  • Journal of traditional and complementary medicine 15(6)
    • Yan Xu
    • Shanshan Han
    • Ting Guo
    • Yudi Li
    • Donglin Li
    • Ying Ding

Study Design

Methods
Network pharmacology, single-cell sequencing, and experimental validation
Funding
Unclear

Background

Qingre huazhuo tang (QRHZT) is a traditional Chinese medicine decoction that has been used clinically by traditional Chinese medicine masters for more than 50 years with good results. However, its mechanism is unknown, and further elucidation is necessary.

Aim of the study

To verify the mechanism by which QRHZT regulates IgA nephropathy through immune checkpoints and ferroptosis by combining network pharmacology, single-cell sequencing and experimental studies.

Materials and methods

The single-cell sequencing data obtained from podocytes of immunoglobulin A (IgA) nephropathy (IgAN) patients were screened, and the QRHZT target information was obtained from the ETCM database. Moreover, the KEGG, GSEA, immune checkpoint and ferroptosis data were analyzed and plotted using R language. Finally, the relevant immune checkpoint and ferroptosis targets were validated experimentally.

Results

QRHZT can regulate IgAN through the immune checkpoints FIT, FTH1, AKR1C3, and IL6 and the ferroptosis-related genes PVR and IFNG.

Conclusion

QRHZT has the potential to regulate IgAN, and omics strategies combined with network pharmacology is a feasible method for exploring the mechanisms of traditional Chinese medicines.

Research Insights

    Back to top